Neumora Therapeutics Shares Are Trading Lower After the Company Announced Its Phase 3 KOASTAL Study Did Not Demonstrate Statistically Significant Improvement on Its Primary Endpoint.
Neumora Therapeutics Shares Are Trading Lower After the Company Announced Its Phase 3 KOASTAL Study Did Not Demonstrate Statistically Significant Improvement on Its Primary Endpoint.
Neumora Therapeutics的股票在公司宣佈其第三階段KOASTAL研究未能在主要終點上顯示統計學顯著改善後，股價下跌。
Neumora Therapeutics Shares Are Trading Lower After the Company Announced Its Phase 3 KOASTAL Study Did Not Demonstrate Statistically Significant Improvement on Its Primary Endpoint.
Neumora Therapeutics的股票在公司宣佈其第三階段KOASTAL研究未能在主要終點上顯示統計學顯著改善後，股價下跌。
熱門討論
特朗普2.0時代開啓，全球股市新風口在哪裏？
▪️加密貨幣政策能否利好crypto? ▪️關稅政策能否利好中概等海外資產？ ▪️在特朗普政策下，有哪些投資機會值得關注？
標普500
01/13 20:53
離川普上臺只有7天了～